Cancer incidence in Iran in 2016: A study based on the Iranian National Cancer Registry
Cancer Reports · 2024
DOI: 10.1002/cnr2.1967 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Reports, 2024. Verfasst von Fatemeh Hadavandsiri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Cancer poses an escalating public health challenge, necessitating a comprehensive understanding of cancer incidence to formulate effective control strategies.
Aims
This study aims to present a comprehensive overview of cancer incidence in Iran, utilizing data from the Iranian National Population‐based Cancer Registry (INPCR) for the year 2016.
Methods
The study employed INPCR data to compute crude and age‐standardized incidence rates (ASR) per 100 000 for the most common cancers among men and women across Iran's 31 provinces. Data analysis utilized Excel (2019) and STATA 14.
Results
In 2016, 124 833 new cancer cases were registered, with 65 495 (52.90%) occurring in men and 58 312 (47.10%) in women. ASRs for all cancers in the total population were 177.48, with specific rates for men and women at 192.96 and 162.33, respectively. The five most common cancers in men were prostate (23.25), stomach (21.56), colon (19.30), bladder (16.20), and lung (13.15). Among women, the leading cancers were breast (40.60), colon (14.64), thyroid (10.84), stomach (10.25), and lung (5.63). West Azarbaijan had the highest incidence among men, while Yazd topped the list for women. Age‐specific incidence rates revealed peaks in the 67–74 age group for men and the 40–50 age group for women.
Conclusion
This study affirms that while Iran exhibits a lower cancer incidence compared to global averages, there has been a temporal increase. Disparities in ASR exist across sexes and provinces, with shifts in the ranking of common cancers by sex compared to previous reports.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Ministry of Health and Medical Education, Tehran, Iran.
- Student Research Committee, School of Public Health and Safety, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand, Iran.
- Department of Health Information Technology and Management, School of Allied Medical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Fatemeh Hadavandsiri, Leila Allahqoli, Yekta Rahimi, Hamid Salehiniya, Ehsan Ghazanfari Savadkoohi, Mohammad Esmaeil Akbari
Zitieren
APA
Hadavandsiri, F., Allahqoli, L., Rahimi, Y., Salehiniya, H., Ghazanfari Savadkoohi, E., & Akbari, M. E. (2024). Cancer incidence in Iran in 2016: A study based on the Iranian National Cancer Registry. Cancer Reports. https://doi.org/10.1002/cnr2.1967
Vancouver
Hadavandsiri F, Allahqoli L, Rahimi Y, Salehiniya H, Ghazanfari Savadkoohi E, Akbari ME. Cancer incidence in Iran in 2016: A study based on the Iranian National Cancer Registry. Cancer Reports. 2024. doi:10.1002/cnr2.1967
BibTeX
@article{Hadavandsiri2024,
author = {Hadavandsiri, Fatemeh and Allahqoli, Leila and Rahimi, Yekta and Salehiniya, Hamid and Ghazanfari Savadkoohi, Ehsan and Akbari, Mohammad Esmaeil},
title = {Cancer incidence in Iran in 2016: A study based on the Iranian National Cancer Registry},
journal = {Cancer Reports},
year = {2024},
doi = {10.1002/cnr2.1967}
}
EUVIMED